UNSPSC 85631333: Replacement of right lower leg skin with autologous tissue substitute, partial thickness, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right lower leg skin with autologous tissue substitute, partial thickness, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HRKX74

UNSPSC 85631333 Replacement of right lower leg skin with autologous tissue substitute, partial thickness, external approach is a Commodity code that shows little relevant recent state and local procurement activity. The recent opportunities tagged under this code span occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, pharmacy benefit management, emergency and specialty healthcare for detained youth, and temporary health professional staffing — none of which involve tissue replacement procedures, surgical implants, or orthopedic reconstruction services that the code nominally describes. The mismatch between the code's clinical scope and the actual work being solicited suggests either inconsistent coding practices in source systems or that this code does not reflect how state and local health systems and benefits administrators currently classify procurement in their jurisdictions.

The issuing bodies posting opportunities with this code tag include a state department of transportation (Washington State Department of Transportation), county-level purchasing for human services and benefits (Collier County, Harris County, Santa Clara County), municipal government (City of Phoenix Retirement Office, City of Long Beach), and county health systems (County of Santa Clara Health System). Activity spans Arizona, California, Florida, Texas, and Washington, with no geographic concentration evident. Without a meaningful recent opportunity that directly matches the code's stated scope, the code presents minimal business-development signal for firms pursuing state and local contracts in tissue substitutes, skin grafts, or related surgical reconstruction materials or services.